Aadi Bioscience: New Data Drives A Beaten Company Down, Not Really Justified
Summary: Aadi Bioscience is a biotech company focused on a nanoliposomal encapsulation of the mTOR inhibitor...
Tag: AADI
Aadi Bioscience: High Risk/High Reward
Summary: Today, we take our first look at a small cap oncology name called Aadi Bioscience, Inc.The firm's main asset is a...
Aadi Bioscience: Commercial Stage With Large Market In Label Expansion
Summary: AADI is a commercial stage company with a potential label expansion ahead.It is adequately funded, run by expert...
Aadi Bioscience: Taking mTOR Inhibition To The Next Level
Summary: Shares have lost half their value since reverse merger with Aerpio Pharmaceuticals.Aadi aims to deliver on the...
Aadi Bioscience: FDA Approval Of Fyarro Only The Beginning
Summary: Aadi Bioscience receives FDA approval of Fyarro for treatment of patients with PEComa.Fyarro (ABI-009) can be...
Aerpio Pharmaceuticals: Is This Stock A Buy Or Sell? Not Until The Merger Is Over
Summary: Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company that is developing compounds that activate Tie2 for...
Aerpio Pharmaceuticals: Eye Spy An Opportunity
Summary: Recent "failure" of lead compound opens up new windows.Let's talk about the pipeline; new methods of attack,...